These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37909577)

  • 1. Dexmedetomidine Preconditioning Attenuates Myocardial Ischemia/Reperfusion Injury in Rats by Suppressing Mitophagy Via Activating Α2-Adrenergic Receptor.
    Chen Y; Chen H; Chen Y; Yang Z; Zhou T; Xu W
    Arq Bras Cardiol; 2023 Oct; 120(10):e20220750. PubMed ID: 37909577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexmedetomidine preconditioning may attenuate myocardial ischemia/reperfusion injury by down-regulating the HMGB1-TLR4-MyD88-NF-кB signaling pathway.
    Zhang JJ; Peng K; Zhang J; Meng XW; Ji FH
    PLoS One; 2017; 12(2):e0172006. PubMed ID: 28222157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cardioprotective effect of dexmedetomidine on regional ischemia/reperfusion injury in type 2 diabetic rat hearts.
    Deng L; Chen H; Wei N; Zhang Z; Wang G
    Microvasc Res; 2019 May; 123():1-6. PubMed ID: 30179598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexmedetomidine preconditioning activates pro-survival kinases and attenuates regional ischemia/reperfusion injury in rat heart.
    Ibacache M; Sanchez G; Pedrozo Z; Galvez F; Humeres C; Echevarria G; Duaso J; Hassi M; Garcia L; Díaz-Araya G; Lavandero S
    Biochim Biophys Acta; 2012 Apr; 1822(4):537-45. PubMed ID: 22230708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dexmedetomidine on myocardial ischemia-reperfusion injury through PI3K-Akt-mTOR signaling pathway.
    Zhang J; Jiang H; Liu DH; Wang GN
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6736-6743. PubMed ID: 31378917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexmedetomidine alleviates H
    Yin W; Wang C; Peng Y; Yuan W; Zhang Z; Liu H; Xia Z; Ren C; Qian J
    Mol Biol Rep; 2020 May; 47(5):3629-3639. PubMed ID: 32342432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexmedetomidine Preconditioning Reduces Myocardial Ischemia-Reperfusion Injury in Rats by Inhibiting the PERK Pathway.
    Chen Y; Cao S; Chen H; Yin C; Xu X; Yang Z
    Arq Bras Cardiol; 2021 Dec; 117(6):1134-1144. PubMed ID: 34644786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Keap1-Nrf2/ARE signal transduction pathway in protection of dexmedetomidine preconditioning against myocardial ischemia/reperfusion injury.
    Li HX; Wang TH; Wu LX; Xue FS; Zhang GH; Yan T
    Biosci Rep; 2022 Sep; 42(9):. PubMed ID: 35959640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clearance of damaged mitochondria via mitophagy is important to the protective effect of ischemic preconditioning in kidneys.
    Livingston MJ; Wang J; Zhou J; Wu G; Ganley IG; Hill JA; Yin XM; Dong Z
    Autophagy; 2019 Dec; 15(12):2142-2162. PubMed ID: 31066324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexmedetomidine protects the heart against ischemia-reperfusion injury by an endothelial eNOS/NO dependent mechanism.
    Riquelme JA; Westermeier F; Hall AR; Vicencio JM; Pedrozo Z; Ibacache M; Fuenzalida B; Sobrevia L; Davidson SM; Yellon DM; Sánchez G; Lavandero S
    Pharmacol Res; 2016 Jan; 103():318-27. PubMed ID: 26607864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tongxinluo Ameliorates Myocardial Ischemia-Reperfusion Injury Mainly via Activating Parkin-Mediated Mitophagy and Downregulating Ubiquitin-Proteasome System.
    Yang HX; Wang P; Wang NN; Li SD; Yang MH
    Chin J Integr Med; 2021 Jul; 27(7):542-550. PubMed ID: 31227964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexmedetomidine pretreatment protects the heart against apoptosis in ischemia/reperfusion injury in diabetic rats by activating PI3K/Akt signaling in vivo and in vitro.
    Chang JH; Jin MM; Liu JT
    Biomed Pharmacother; 2020 Jul; 127():110188. PubMed ID: 32407987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of G protein-coupled oestrogen receptor 1 at the onset of reperfusion protects the myocardium against ischemia/reperfusion injury by reducing mitochondrial dysfunction and mitophagy.
    Feng Y; Madungwe NB; da Cruz Junho CV; Bopassa JC
    Br J Pharmacol; 2017 Dec; 174(23):4329-4344. PubMed ID: 28906548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Apelin-13 promotes mitochondrial autophagy and improves rat myocardial ischemia-reperfusion injury by blocking PINK1/parkin signaling pathway].
    Liang R; Wang T; Lin D; Yin X; Lin L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Number; 39(11):981-987. PubMed ID: 37980549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexmedetomidine preconditioning attenuates ischemia/reperfusion injury in isolated rat hearts with endothelial dysfunction.
    He L; Hao S; Wang Y; Yang W; Liu L; Chen H; Qian J
    Biomed Pharmacother; 2019 Jun; 114():108837. PubMed ID: 30965239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexmedetomidine Provides Cardioprotection During Early or Late Reperfusion Mediated by Different Mitochondrial K+-Channels.
    Raupach A; Karakurt E; Torregroza C; Bunte S; Feige K; Stroethoff M; Brandenburger T; Heinen A; Hollmann MW; Huhn R
    Anesth Analg; 2021 Jan; 132(1):253-260. PubMed ID: 32889843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexmedetomidine preconditioning for myocardial protection in ischaemia-reperfusion injury in rats by downregulation of the high mobility group box 1-toll-like receptor 4-nuclear factor κB signalling pathway.
    Yang YF; Peng K; Liu H; Meng XW; Zhang JJ; Ji FH
    Clin Exp Pharmacol Physiol; 2017 Mar; 44(3):353-361. PubMed ID: 27998004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexmedetomidine protects the heart against ischemia reperfusion injury via regulation of the bradykinin receptors.
    Song J; Du J; Tan X; Wu Z; Yuan J; Cong B
    Eur J Pharmacol; 2021 Nov; 911():174493. PubMed ID: 34506777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electroacupuncture preconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting mitophagy mediated by the mTORC1-ULK1-FUNDC1 pathway.
    Xiao Y; Chen W; Zhong Z; Ding L; Bai H; Chen H; Zhang H; Gu Y; Lu S
    Biomed Pharmacother; 2020 Jul; 127():110148. PubMed ID: 32344255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shenxian-Shengmai Oral Liquid Reduces Myocardial Oxidative Stress and Protects Myocardium from Ischemia-Reperfusion Injury.
    Zhao Y; Zhang X; Luan J; Zhao B; An N; Sun N; Wang X; Zhao T; Sun Y; Fu ZD; Zhang Y; Zhang Y
    Cell Physiol Biochem; 2018; 48(6):2503-2516. PubMed ID: 30121659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.